Cingulate Therapeutics
Amendment
CIK: 0001593151·Pharmaceuticals·DELAWARE·Filed: Jun 29, 2020
Total Offering
Indefinite
Amount Sold
$26,200,000
Investors
203
First Sale
Nov 14, 2013
Offering Details
- Type
- Equity, Debt, Option to Acquire, Security to be Acquired, Other: Membership Units, Profits Interest Units
- Exemptions
- Rule 506(b), Section 4(a)(5)
- Entity Type
- Limited Liability Company
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Louis George Van Horn | Related Person |
| Shane J Schaffer | Related Person |
| Craig Steven Gilgallon | Related Person |
| Matthew N Brams | Related Person |
| Raul R Silva | Related Person |
| Laurie A Myers | Related Person |
| Arthur B Straughn | Related Person |
| Patrick J Gallagher | Related Person |
| Jeff Hargroves | Related Person |
| Peter J Werth | Related Person |
| Jeff Conroy | Related Person |
Company
SEC Filing
0001593151-20-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free